generic medicines
Coverage of generic medicines in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more
President Trump plans to impose 100% tariffs on imported generic medicines starting in August 2028, increasing to 200% in 2029, aiming to bring pharmaceutical manufacturing to the U.S. Critics warn this could raise drug costs, cause shortages, and disrupt supply chains. Indian drugmakers, a major U.S. generic drug supplier, have been unsettled by the proposal.
- EU says Trump’s new generic drug tariffs won’t hit its exports
The European Commission claims EU generic medicines will be exempt from Trump’s proposed 100% tariffs starting 2028, citing the 2025 Turnberry trade deal that ensures a 0% most-favored-nation tariff rate. Trump’s plan aims to boost U.S. pharmaceutical production but faces EU assertions that the deal protects European exports from higher levies.